InDex Pharmaceuticals

InDex Pharmaceuticals is a company listed under the stock ticker INDEX (SE).

View the org chart displaying its 10 main executives

Most searched biographies at InDex Pharmaceuticals

• Jenny Sundqvist, Chief Executive Officer (until Sep 26 2024)
• Wenche Rolfsen, Chairman of the Board
• Karin Bernadotte Af Wisborg, Board Member

Popular executive movements at InDex Pharmaceuticals

• Jenny Sundqvist, Chief Executive Officer, will leave the company on Sep. 26, 2024  (posted on March 27 2024).
• Johan Giléus, Chief Financial Officer and Board Member, will leave the company on Sep. 26, 2024  (posted on March 27 2024).

Create your alert
to follow the executive moves at InDex Pharmaceuticals.

InDex Pharmaceuticals has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by InDex Pharmaceuticals

• Press releases - InDex Pharmaceuticals
• Press releases - InDex Pharmaceuticals

Social media about InDex Pharmaceuticals

• InDex Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• InDex Pharmaceuticals on LinkedIn, Twitter & YouTube

Contact by email its executives including Wenche Rolfsen

Call InDex Pharmaceuticals at +46 81...

View the org chart

Register to receive your alert

Report an error